Unverified50% confidenceCautionExact time

A positive amyloid pathology biomarker does not mean an individual will necessarily develop Alzheimer's disease dementia, and there is a risk of overdiagnosis.

1

Sources

50%

Confidence

Long-term

Relevance

8/30/2026

First Seen

Sources

FDA Approves Blood Test for Alzheimer's Disease: A Major Step Toward Lowering the Barrier to Early Screening

Related Entities

阿尔茨海默病血液检测product

Related Claims

Unverified高认知储备者即便出现与阿尔茨海默病患者相当程度的β-淀粉样蛋白沉积，也能维持更长时间的正常认知功能78% similar Unverifiedβ-淀粉样蛋白（Aβ）假说自1991年提出以来一直是阿尔茨海默症研究的主导范式77% similar UnverifiedTREM2的功能缺失突变（如R47H）被GWAS确认为阿尔茨海默症最强的单基因风险因子之一，携带者患病风险提高2-4倍73% similar

Cite This Claim

Stable URI

https://kongchang.com/claim/823844

API

curl https://kongchang.com/api/v1/knowledge/claims/823844

MCP

get_claim(id=823844)